The influence of year-end bonuses on colorectal cancer screening

American Journal of Managed Care

Volumn 10, Issue 9, 2004, Pages 617-624

  Armour, Brian S ^a   Friedman, Carol ^a   Pitts, M Melinda ^b   Wike, Jennifer ^c   Alley, Linda ^a   Etchason, Jeff ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b FEDERAL RESERVE BANK OF ATLANTA   (United States)

^c Georgia and Kerr L White Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARIUM ENEMA; CANCER SCREENING; CLINICAL PRACTICE; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MONEY; MOTIVATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCULT BLOOD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SIGMOIDOSCOPY;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; MASS SCREENING; MIDDLE AGED; PHYSICIAN INCENTIVE PLANS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 4644335576     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. American Cancer Society. Cancer Facts and Figures, 2003. Atlanta, Ga: American Cancer Society; 2003. Publication 5008.03.
2. Moore C. Screening is key to preventing colorectal cancer. Bus Health. 2001;19:40.
3. Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged ≥50 years, United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52:193-196.
4. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale [published corrections appear in Gastroenterology. 1997;112:1060 and Gastroenterology. 1998;114:625]. Gastroenterology. 1997;112:594-642.
5. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale [published corrections appear in Gastroenterology. 1997;112:1060 and Gastroenterology. 1998;114:625]. Gastroenterology. 1997;112:594-642.
6. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale [published corrections appear in Gastroenterology. 1997;112:1060 and Gastroenterology. 1998;114:625]. Gastroenterology. 1997;112:594-642.
7. Smith RA, von Eschenbach AC, Wender R, et al, ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers: also: update 2001: testing for early lung cancer detection. CA Cancer J Clin. 2001;51:38-75.
8. US Preventive Services Task Force, Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
9. Selby JV, Friedman CD, Quesenberry CP Jr, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer: a case-control study. Ann Intern Med. 1993;118:1-6.
10. Winawer SJ, Zauber AC, O'Brien MJ, et al, National Polyp Study Workgroup. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med. 1993;328:901-906.
11. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
12. Mandelbatt JS, Yarbroff KR, Kerner JF. Equitable access to cancer services: a review of barriers to quality care. Cancer. 1999;86:2378-2390.
13. Glied S. Managed care. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam, the Netherlands: Elsevier Sciences Ltd; 2000:707-753.
14. Armour BS, Pitts MM. Physician financial incentives in managed care: resource use, quality and cost implications. Dis Manag Health Outcomes. 2003;11:139-147.
15. Pegram v Hedrich, 530 US 211 (2000).
16. Grumbach K, Osmond D, Vranizan K, Jaffe D, Bindman AB. Primary care physicians' experience of financial incentives in managed-care systems. N Engl J Med. 1998;339:1516-1521.
17. Lee-Feldstein A, Feldstein PJ, Buchmueller T. Health care factors related to stage at diagnosis and survival among Medicare patients with colorectal cancer. Med Care. 2002;40:362-374.
18. Armour BS, Pitts MM, Maclean R, et al. The effect of explicit financial incentives on physician behavior. Arch Intern Med. 2001;161:1261-1266.
19. Shaheen NJ, Ransohoff DF. Sigmoidoscopy costs and the limits of altruism [editorial]. Am J Med. 1999;107:286-287.
20. Lewis JD, Asch DA. Barriers to office-based screening Sigmoidoscopy: does reimbursement cover costs? Ann Intern Med. 1999;130:525-530.
21. Hardy RE, Ahmed NU, Hargreaves MK, et al. Difficulty in reaching low-income women for screening mammography. J Health Care Poor Underserved. 2000;11:45-57.
22. Suarez L, Roche RA, Nichols D, Simpson DM. Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women. Am J Prev Med. 1997;13:137-142.
23. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:326-331.
24. Gregorio DI, Walsh SJ, Tate JP. Diminished socioeconomic and racial disparity in the detection of early-stage breast cancer, Connecticut, 1986-1995. Ethn Dis. 1999;9:396-402.
25. Campbell RJ, Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Herold A. Predictors of advanced stage colorectal cancer diagnosis: results of a population-based study. Cancer Detect Prev. 2001;25:430-438.
26. Polednak AP. Poverty, comorbidity, and survival of colorectal cancer patients diagnosed in Connecticut. J Health Care Poor Underserved. 2001;12:302-310.
27. Kerner JF, Mandelblatt JS, Silliman RA, et al, OPTIONS Research Team. Screening mammography and breast cancer treatment patterns in older women: Outcomes and Preferences for Treatment in Older Women Nationwide Study. Breast Cancer Res Treat. 2001;69:81-91.
28. US Bureau of the Census. Census 2000: Summary File 3: Census of Population and Housing. Washington, DC: US Bureau of the Census; 2002.
29. Weinrich SP. Predictors of older adults' participation in fecal occult blood screening. Oncol Nurs Forum. 1990;17:715-720.
30. Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002;162:2581-2586.
31. Holtzman D, Bland SD, Lansky A, Mack KA. HIV-related behaviors and perceptions among adults in 25 states: 1997 Behavioral Risk Factor Surveillance System. Am J Public Health. 2001;91:1882-1888.
32. Cooper GS, Yuan Z, Rimm AA. Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev. 1997;6:283-285.
33. O'Malley AS, Forrest CB, Mandelblatt J. Adherence of low-income women to cancer screening recommendations. J Gen Intern Med. 2002;17:144-154.
34. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys J Natl Cancer Inst. 2001;93:1704-1713.
35. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85:840-842.
36. Borum ML. Cancer screening in women by internal medicine resident physicians. South Med J. 1997;90:1101-1105.
37. Herman CJ, Hoffman RM, Altobelli KK. Variation in recommendations for cancer screening among primary care physicians in New Mexico. J Community Health. 1999;24:253-267.
38. Weitzman ER, Zapka J, Estabrook B, Coins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med. 2001;32:502-513.
39. Studemund AH. Using Econometrics: A Practical Guide. New York, NY: Addison Wesley Longman Inc; 2001:167.
40. Balkrishnan R, Hall MA, Mehrabi D, Chen GJ, Feldman SR, Fleischer AB Jr. Capitation payment, length of visit, and preventive services: evidence from a national sample of outpatient physicians. Am J Manag Care. 2002;8:332-340.
41. Lurie N, Margolis KL, McGovern PG, Mink PJ, Slater JS. Why do patients of female physicians have higher rates of breast and cervical cancer screening? J Gen Intern Med. 1997;12:34-43.
42. Greene WH. Econometric methods. Centers for Disease Control and Prevention Workshop; August 16-17, 2002; Atlanta, Ga.
43. Hillman AL, Ripley K, Goldfarb N, Nuamah I, Weiner I, Lusk E. Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. Am J Public Health. 1998;88:1699-1701.
44. Debrock L, Arnould RJ. Utilization control in HMOs. Q Rev Econ Finance. 1992;32:31-53.
45. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA, American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Cancer J Clin. 1997;47:154-160.
46. Geronimus A, Bound J, Neidert L. On the Validity of Using Census Geocode Characteristics to Proxy Individual Socioeconomic Characteristics. Cambridge, Mass: National Bureau of Economic Research; 1995:1-19. NBER Technical Working Paper 189. Available at: http://dsl.nber.org/papers/t0189.pdf. Accessed February 21, 2004.
47. Wise PH, Kotelchuck M, Wolson ML, Mills M. Racial and socioeconomic disparities in childhood mortality in Boston. N Engl J Med. 1985;313:360-366.
48. Could JB, Davey B, LeRoy S. Socioeconomic differentials and neonatal mortality: racial comparison of California singletons. Pediatrics. 1989;83:181-186.
49. Could JB, LeRoy S. Socioeconomic status and low birth weight: a racial comparison. Pediatrics. 1988;82:896-904.
50. Collins JW, David RJ. Differences in neonatal mortality by race, income, and prenatal care. Ethn Dis. 1992;2:18-26.
51. Liu L, Deapen D, Bernstein L. Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control. 1998;9:369-380.
52. Etchason J, Armour B, Ofili E, et al. Racial and ethnic disparities in health care [letter]. JAMA. 2001;285:883.
53. Bound J, Brown C, Duncan G, Rodgers W. Evidence in the validity of cross sectional and labor market data. J Labor Econ. 1992;12:345-368.
54. Lee L, Sepanski JH. Consistent estimation of linear and non-linear errors-invariables models and validation information. J Am Stat Assoc. 1995;90:130-140.
55. Kane RL, Johnson PE, Town RJ, Butler M. Economic Incentives: Evidence Report/Technology Assessment: Prepared by the Minnesota Evidence-Based Practice Center Under Contract No. 290.02.0009. Rockville, Md: Agency for Healthcare Research and Quality. AHRQ publication. In press.
56. Nelson RL, Dollear T, Freels S, Persky V. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer. 1997;80:193-197.
57. Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848-856.